Alzheimer Disease
Showing NaN - NaN of 42
Alzheimer Trial in Worldwide (bapineuzumab, )
Alzheimer Trial in Worldwide (Bapineuzumab 0.5 mg/kg)
Terminated
- Alzheimer Disease
- Bapineuzumab 0.5 mg/kg
-
Birmingham, Alabama
- +182 more
Nov 30, 2015
Alzheimer Trial in Portland (Salvia officinalis (sage))
Completed
- Alzheimer Disease
- Salvia officinalis (sage)
-
Portland, OregonOregon Health and Science University
Oct 27, 2014
Alzheimer Trial in Canada, United States (NS 2330 (Tesofensine))
Completed
- Alzheimer Disease
- NS 2330 (Tesofensine)
-
Mesa, Arizona
- +86 more
Oct 28, 2013
Alzheimer Trial in Worldwide (Rivastigmine 5 cm^2, Rivastigmine 10 cm^2, Rivastigmine 15 cm^2)
Completed
- Alzheimer Disease
- Rivastigmine 5 cm^2
- +4 more
-
Birmingham, Alabama
- +144 more
Sep 17, 2012
Alzheimer Trial in United States (Investigational drug)
Terminated
- Alzheimer Disease
- Investigational drug
-
Peoria, Arizona
- +33 more
Dec 10, 2009
Alzheimer Trial in Canada, United States (xaliproden (SR57746A))
Completed
- Alzheimer Disease
- xaliproden (SR57746A)
-
Birmingham, Alabama
- +120 more
Aug 20, 2008
Alzheimer Trial in United States (Huperzine A)
Completed
- Alzheimer Disease
- Huperzine A
-
Birmingham, Alabama
- +28 more
Feb 19, 2008
Healthy Aging and Memory Study
Completed
- Alzheimer Disease
-
Birmingham, Alabama
- +38 more
Sep 14, 2007